Specializing in diagnostic testing solutions, this company develops and manufactures tests for infectious diseases, gastrointestinal infections, and lead poisoning. Investors monitor its performance due to its niche position in life science tools and recurring revenue from clinical labs.
3 members of Congress have disclosed 8 trades in Meridian Bioscience, Inc. (VIVO), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-02-23 | Tom Malinowski | sell | $1K – $15K |
| 2020-11-13 | Tom Malinowski | sell | $1K – $15K |
| 2020-09-16 | Tom Malinowski | sell | $1K – $15K |
| 2020-09-15 | Tom Malinowski | sell | $1K – $15K |
| 2020-08-31 | Tom Malinowski | sell | $1K – $15K |
| 2015-02-19 | JAMES B. RENACCI | buy | $15K – $50K |
| 2008-12-02 | MICHAEL T. MCCAUL | sell | — |
| 2008-12-02 | MICHAEL T. MCCAUL | buy | — |